Dermatofibroma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
Line 1: Line 1:
__NOTOC__
{{Dermatofibroma}}
{{Dermatofibroma}}
{{CMG}}
{{CMG}}, {{AE}}{{Homa}}


==Overview==
==Overview==

Revision as of 18:28, 5 June 2019

Dermatofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatofibroma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatofibroma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatofibroma epidemiology and demographics

CDC on Dermatofibroma epidemiology and demographics

Dermatofibroma epidemiology and demographics in the news

Blogs on Dermatofibroma epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Dermatofibroma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Dermatofibromas occur most often in women; the male to female ratio is about 1:4. The age group in which they most commonly occur is twenty to forty-five years.

Epidemiology and Demographics

Dermatofibromas occur most often in women; the male to female ratio is about 1:4. The age group in which they most commonly occur is twenty to forty-five years.